Severe venous thromboembolism in a young man with Klinefelter's syndrome and heterozygosis for both G20210A prothrombin and factor V Leiden mutations

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 1, 2003, Pages 95-98

  Lapecorella, Mario ^a   Marino, Renato ^a   De Pergola, Giovanni ^a   Scaraggi, Francesco A ^a   Speciale, Vincenzo ^a   De Mitrio, Vito ^a  

^a NONE

Author keywords

Factor V Leiden; G20210A prothrombin; Klinefelter's syndrome; Venous thromboembolism

Indexed keywords

ANDROGEN; BLOOD CLOTTING FACTOR 5 LEIDEN; GONADOTROPIN; PROTHROMBIN; TESTOSTERONE;

ADULT; ARTICLE; AZOOSPERMIA; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; EUNUCHOIDISM; FIBRINOLYSIS; GENE MUTATION; GYNECOMASTIA; HETEROZYGOSITY; HORMONE DEFICIENCY; HUMAN; KLINEFELTER SYNDROME; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SPERMATOGENESIS; TESTIS DISEASE; TESTOSTERONE SYNTHESIS; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

ADULT; FACTOR V; HETEROZYGOTE; HUMANS; KLINEFELTER SYNDROME; MALE; POINT MUTATION; PROTHROMBIN; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 12244263504     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200301000-00017     Document Type: Article

References (23)

1. Plymate SR. Male hypogonadism. In: Becker KL. (editor): Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 1125-1150.
2. Wang C, Baker HW, Burger HG, De Kretser DM, Hudson B. Hormonal studies in Klinefelter's syndrome. Clin Endocrinol (Oxford) 1975; 4:399-411.
3. Swerdlow AJ, Hermon C, Jacobs PA, Alberman E, Beral V, Daker M, et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet 2001; 65:177-188.
4. Aoki N. Klinefelter's syndrome, autoimmunity, and associated endocrino-pathies. Intern Med 1999; 38:838-839.
5. Verp MS, Simpson JL, Martin AO. Hypostatic ulcers in 47, XXY Klinefelter's syndrome. J Med Genet 1983; 20:100-101.
6. Fricke GR, Mattern HJ, Schweikert HU, Schwanitz G. Klinefelter's syndrome and mitral valve prolapse, an echocardiographic study in twenty-two patients. Biomed Pharmacother 1984; 38:88-97.
7. Campbell WA, Price WH. Venous thromboembolic disease in Klinefelter's syndrome. Clin Genet 1981; 19:275-280.
8. Depaire-Duclos F, Gris JC, Dandurand M, Guillot B. Thrombotic Klinefelter syndrome associated with Factor V Leiden mutation. Arch Dermatol 1997; 133:1051-1052.
9. Ranganath LR, Jones L, Lim AG, Gould SR, Goddard PF. Thrombophilia in a man with long-standing hypogonadism. Postgrad Med J 1997; 73:761-763.
10. De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, et al. Low andogenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism 1997; 46:1287-1293.
11. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. et al. Mutation in blood coagulation Factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
12. Poort SR, Rosendaal FR, Reitsma PM, Bertina RM. A common genetic variation in the 3′ -untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
13. Froost P, Blom Hj, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methilenetetrahydrofolate reductase. Nat Gen 1995; 10:111-113.
14. Bennet A, Sie P, Caron P, Boneu B, Bazex J, Pontonnier F, et al. Plasma fibrinolytic activity in a group of hypogonadic men. Scand J Clin Lab Invest 1987; 47:23-27.
15. Caron P, Bennet A, Camare R, Louvet JP, Boneu B, Sie P. Plasminogen activator inhibitor in plasma is related to testosterone in men. Metabolism 1989; 38:1010-1015
16. Winkler UH. Effects of androgens on haemostasis. Maturitas 1996; 24:147-155.
17. Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castman G, Mannucci PM. The risk of venous tromboembolism in family members with mutations in the genes of factor V, prothrombin or both. Br J Haematol 2001; 111:1223-1229.
18. Kluft C, Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997; 78:315-326.
19. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001; 86:112-123.
20. Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344:1453-1457.
21. Martinelli I, Taioli E, Bucciarelli P, Akhavan S, Mannucci PM. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol 1999; 19:700-703.
22. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999; 341:801-806.
23. Margaglione M, D'Andrea G, Colaizzo D, Cappucci G, Del Popolo A, Brancaccio V, et al. Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost 1999; 82:1583-1587.